person

Torbjørn O.

Country
Norway
Department
Division of Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 4 partner sites.

Specializations

Cardiovascular Medicine

The investigator focuses on atherosclerotic cardiovascular disease, atrial fibrillation and various forms of heart failure, addressing both acute events such as myocardial infarction and chronic management of vascular risk.

  • Atherosclerotic cardiovascular disease (ASCVD)
  • Atrial fibrillation in chronic kidney disease
  • Heart failure with preserved ejection fraction
  • Ischemic stroke prevention
  • Venous thromboembolism

Primary clinical activities are conducted at Akershus University Hospital in Lorenskog, Norway.

Hepatology & Metabolic Liver Disease

Research efforts target progressive liver conditions including non‑alcoholic steatohepatitis and cholestatic disorders such as primary sclerosing cholangitis and primary biliary cholangitis, often linked to metabolic risk factors.

  • Non‑Alcoholic Steatohepatitis (NASH)
  • Primary sclerosing cholangitis (PSC)
  • Primary biliary cholangitis (PBC)
  • Liver fibrosis and cirrhosis
  • Metabolic syndrome associated liver disease

The work integrates hepatology expertise within the Division of Medicine.

Oncology & Hematology

Clinical investigations span solid tumors and hematologic malignancies, encompassing breast cancer, lung cancer, colorectal cancer, and blood cancers such as acute myeloid leukemia and chronic lymphocytic leukemia.

  • Breast cancer (including triple‑negative)
  • Non‑small cell lung cancer
  • Colorectal carcinoma
  • Acute myeloid leukemia (AML)
  • Chronic lymphocytic leukemia (CLL)
  • Metastatic prostate cancer

The oncology portfolio supports both early‑stage and advanced disease settings.

Pulmonary & Respiratory Disorders

Investigations include chronic and interstitial lung diseases such as chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and immune‑mediated conditions like pulmonary sarcoidosis.

  • Chronic obstructive pulmonary disease (COPD)
  • Idiopathic pulmonary fibrosis (IPF)
  • Active pulmonary sarcoidosis
  • Severe asthma with eosinophilic phenotype
  • Respiratory infections (including COVID‑19)

These studies aim to improve outcomes for patients with progressive respiratory pathology.

Neurology & Neurodegenerative Diseases

The investigator engages in research on neurocognitive and neurodegenerative disorders, notably Alzheimer’s disease, amyotrophic lateral sclerosis, and various forms of dementia.

  • Alzheimer’s disease
  • Amyotrophic lateral sclerosis (ALS)
  • Dementia with Lewy bodies
  • Mild cognitive impairment
  • Major depressive disorder

Efforts are directed toward understanding disease mechanisms and therapeutic potential.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.